Northern Trust’s AbbVie ABBV Stock Holding History

Northern Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61B	Sell	21,211,382 -522,541	-2%	-$116M	0.61%	20
2025 Q4	$4.97B	Sell	21,733,923 -312,304	-1%	-$71.1M	0.63%	19
2025 Q3	$5.1B	Buy	22,046,227 +32,853	+0.1%	+$6.69M	0.65%	19
2025 Q2	$4.09B	Sell	22,013,374 -546	-0%	-$101K	0.56%	25
2025 Q1	$4.61B	Buy	22,013,920 +189,294	+0.9%	+$36.8M	0.68%	21
2024 Q4	$3.88B	Buy	21,824,626 +2,299,645	+12%	+$423M	0.55%	25
2024 Q3	$3.86B	Sell	19,524,981 -759,111	-4%	-$142M	0.63%	22
2024 Q2	$3.48B	Buy	20,284,092 +33,832	+0.2%	+$5.6M	0.59%	23
2024 Q1	$3.69B	Sell	20,250,260 -685,853	-3%	-$118M	0.64%	22
2023 Q4	$3.24B	Sell	20,936,113 -1,000,166	-5%	-$146M	0.59%	24
2023 Q3	$3.27B	Buy	21,936,279 +491,391	+2%	+$72.1M	0.63%	23
2023 Q2	$2.89B	Sell	21,444,888 -780,116	-4%	-$114M	0.56%	26
2023 Q1	$3.54B	Buy	22,225,004 +268,579	+1%	+$41.1M	0.7%	21
2022 Q4	$3.55B	Buy	21,956,425 +101,629	+0.5%	+$15.6M	0.74%	19
2022 Q3	$2.93B	Sell	21,854,796 -319,948	-1%	-$45.9M	0.67%	21
2022 Q2	$3.4B	Sell	22,174,744 -456,417	-2%	-$69.7M	0.73%	22
2022 Q1	$3.67B	Sell	22,631,161 -186,365	-0.8%	-$27.1M	0.65%	21
2021 Q4	$3.09B	Buy	22,817,526 +1,806	+0%	+$213K	0.51%	30
2021 Q3	$2.46B	Buy	22,815,720 +161,083	+0.7%	+$18.4M	0.44%	41
2021 Q2	$2.55B	Sell	22,654,637 -1,072,864	-5%	-$121M	0.45%	35
2021 Q1	$2.57B	Sell	23,727,501 -185,978	-0.8%	-$19.9M	0.48%	32
2020 Q4	$2.56B	Sell	23,913,479 -449,713	-2%	-$43.2M	0.5%	31
2020 Q3	$2.13B	Buy	24,363,192 +210,056	+0.9%	+$19.8M	0.47%	39
2020 Q2	$2.37B	Buy	24,153,136 +3,808,707	+19%	+$335M	0.56%	29
2020 Q1	$1.55B	Buy	20,344,429 +895,939	+5%	+$76.3M	0.45%	45
2019 Q4	$1.72B	Sell	19,448,490 -182,144	-0.9%	-$15.1M	0.39%	49
2019 Q3	$1.49B	Sell	19,630,634 -525,315	-3%	-$36M	0.36%	51
2019 Q2	$1.47B	Sell	20,155,949 -56,135	-0.3%	-$4.41M	0.35%	53
2019 Q1	$1.63B	Sell	20,212,084 -817,581	-4%	-$66.9M	0.4%	47
2018 Q4	$1.94B	Buy	21,029,665 +227,408	+1%	+$20M	0.54%	32
2018 Q3	$1.97B	Sell	20,802,257 -425,114	-2%	-$40.3M	0.48%	33
2018 Q2	$1.97B	Sell	21,227,371 -425,398	-2%	-$41.5M	0.5%	33
2018 Q1	$2.05B	Sell	21,652,769 -449,836	-2%	-$49.4M	0.53%	31
2017 Q4	$2.14B	Sell	22,102,605 -220,261	-1%	-$20.8M	0.54%	31
2017 Q3	$1.98B	Buy	22,322,866 +1,219,921	+6%	+$92.9M	0.52%	36
2017 Q2	$1.53B	Sell	21,102,945 -219,511	-1%	-$14.8M	0.43%	42
2017 Q1	$1.39B	Sell	21,322,456 -133,177	-0.6%	-$8.37M	0.4%	43
2016 Q4	$1.34B	Sell	21,455,633 -220,741	-1%	-$13.5M	0.41%	43
2016 Q3	$1.37B	Sell	21,676,374 -303,888	-1%	-$19.7M	0.43%	45
2016 Q2	$1.36B	Sell	21,980,262 -47,319	-0.2%	-$2.88M	0.44%	47
2016 Q1	$1.26B	Sell	22,027,581 -292,030	-1%	-$16.3M	0.42%	48
2015 Q4	$1.32B	Sell	22,319,611 -1,497,409	-6%	-$86.2M	0.44%	46
2015 Q3	$1.3B	Sell	23,817,020 -1,766,035	-7%	-$115M	0.43%	46
2015 Q2	$1.72B	Buy	25,583,055 +1,335,123	+6%	+$87.2M	0.52%	33
2015 Q1	$1.42B	Sell	24,247,932 -106,888	-0.4%	-$6.46M	0.43%	47
2014 Q4	$1.59B	Sell	24,354,820 -112,783	-0.5%	-$7.11M	0.48%	38
2014 Q3	$1.41B	Sell	24,467,603 -977,586	-4%	-$54.3M	0.44%	39
2014 Q2	$1.44B	Sell	25,445,189 -152,622	-0.6%	-$8.01M	0.45%	41
2014 Q1	$1.32B	Sell	25,597,811 -256,430	-1%	-$13M	0.41%	45
2013 Q4	$1.37B	Buy	25,854,241 +510,071	+2%	+$25.1M	0.44%	42
2013 Q3	$1.13B	Sell	25,344,170 -961,821	-4%	-$42.6M	0.4%	46
2013 Q2	$1.09B	Buy	+26,305,991	New	+$1.15B	0.39%	46

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust's ABBV Position: Q1 2026 in Review

Northern Trust reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $116M and leaving 21,211,382 shares worth $4.61B. The position accounts for 0.61% of the portfolio, ranked #20.

Northern Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.1B in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Northern Trust held 21,211,382 shares of AbbVie worth $4.61B as of Q1 2026.
Northern Trust sold 522,541 AbbVie shares in Q1 2026, an estimated $116M.
AbbVie made up 0.61% of Northern Trust's portfolio in Q1 2026, its #20 holding.
Northern Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Northern Trust's AbbVie position peaked at $5.1B in Q3 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.